Read More Pharma Industry News Bristol Myers Squibb announces success of KRAZATI in Phase 3 KRYSTAL-12 study Bristol Myers Squibb (NYSE: BMY) has reached a pivotal milestone in the treatment of non-small cell lung cancer… byPallavi MadhirajuApril 1, 2024